The global meningitis vaccine market is segmented into vaccines such as polysaccharide vaccines, conjugate vaccines and combination vaccines. Among these segments, combination vaccine is expected to grow at the highest CAGR in the overall meningitis vaccine market during the forecast period. Increasing utilization of combination vaccines for the prevention of disease in infants is the major factor behind the growth of the combination meningitis vaccine segment. Furthermore, newly developed combination vaccines with higher efficiency are expected to augment the growth of the combination meningitis vaccine market.
The global meningitis vaccine market is expected to flourish at CAGRof 14.5% over the forecast period. Moreover, the global meningitis vaccine market is anticipated to garner USD 5.2 Billion by the end of 2023. Factors such as rising incidents of meningitis in infants and the introduction of cost-effective meningitis vaccines are some of the major factors behind the growth of the meningitis vaccine market.
North America dominated the overall market of meningitis vaccines and is expected to continue its dominance over the forecast period. This can be attributed to favorable government initiatives and adequate awareness of meningitis disease in the region. Further, the development and availability of advanced meningitis vaccines by key manufacturers such as Novartis and Pfizerisexpected to positively impact the growth of the meningitis vaccine market in the North American region. The Asia Pacific is anticipated to witness lucrative growth over the forecast period. Factors such as rising awareness towards meningitis disease and penetration of low-cost meningitis vaccines in the region are likely to impel the growth of the meningitis vaccine market.
Get a PDF Sample for more detailed market insights: https://www.researchnester.com/sample-request-231
Increased Prevalence of Disease
The high prevalence of meningitis in young infants in Africa and other regions is expected to impel the demand for meningitis vaccines in the upcoming years. Moreover, various awareness programs conducted by healthcare organizations across the globe are anticipated to foster the growth of the meningitis vaccine market.
Development of New Advanced Formulas
The development of new vaccines such as meningitis B vaccines is expected to be the major driving factor for the meningitis vaccine market over the forecast period.Apart from this, increasing concern regarding the preventive healthcare of infants is anticipated to foster the growth ofmeningitis vaccine market.
Although, lack of awareness in undeveloped nations is likely to inhibit the growth of the globalmeningitis vaccinemarket in the near future.
Further, for the in-depth analysis, the report encompasses the industry growth drivers, restraints, supply and demand risk, market attractiveness, BPS analysis and Porter’s five force model.
For more information about this report visit: https://www.researchnester.com/sample-request-231
This report also provides the existing competitive scenario of some of the key players of the globalmeningitis vaccinemarket which includes company profiling ofGlaxoSmithKline plc,Baxter International, Pfizer Inc., Sanofi Pasteur SA, Merck & Co., Inc., Zhejiang Tianyuan Bio-Pharmaceutical Co. Ltd., Beijing Tiantan Biological, Novartis AG and Big Pharma. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the globalmeningitis vaccinemarket that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.
About Research Nester
Research Nester is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates and executives to take wise decisions for their future marketing strategy, expansion and investment etc. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wise decision so as to avoid future uncertainties.
Contact Us
AJ Daniel
Email: [email protected]
U.S. Phone: [+1 646 586 9123]
U.K. Phone: [+44 203 608 591]
Meningitis B Market report published by Value Market Research, which studies the future outlook of the market.
It includes the size, share, growth, trends, key players, segments and regional analysis in detail during the study year 2020-2027.The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide.
The major players in the meningitis b market include Eurofins Viracor, Inc., HiberGene Diagnostics, Thermo Fisher Scientific, Inc., Siemens Healthineers, Bio-Rad Laboratories, Inc., IMMY, BioFire Diagnostics, Qnostics, ELITechGroup, and Abbott Laboratories.
This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.Get more information on "Global Meningitis B Market Research Report" by requesting FREE Sample Copy at https://www.valuemarketresearch.com/contact/meningitis-b-market/download-sampleMarket DynamicsThe rising prevalence of meningitis B worldwide drives the global meningitis B treatment market.
As per the Centers for Diseases Control and Prevention, over 1.2 million cases of bacterial meningitis are estimated to occur worldwide each year.
The prevalence is witnessing an increasing trend due to the growing abuse of alcohol and weakening the autoimmune system.
